|

benralizumab Clinical Trials

3 actively recruiting trials across 2 locations

▲ +1 trial since August 2026

Also known as: Fasenra

Pipeline

Phase 3: 1Phase 4: 1

Top Sponsors

  • AstraZeneca2
  • University of California, San Diego1

Indications

  • Asthma3
  • Hypereosinophilic Syndrome (HES)1
  • Eosinophilic Granulomatosis With Polyangiitis (EGPA)1
  • Severe Eosinophilic Asthma1
  • Moderate to Severe Asthma1

Other1 trial

A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy

Scottsdale, Arizona1 trial

Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping

Mayo Clinic

Phase 4

Aurora, Colorado1 trial

Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

Research Site

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.